ID 8 structure
|
Common Name | ID 8 | ||
---|---|---|---|---|
CAS Number | 147591-46-6 | Molecular Weight | 298.293 | |
Density | 1.3±0.1 g/cm3 | Boiling Point | 418.3±45.0 °C at 760 mmHg | |
Molecular Formula | C16H14N2O4 | Melting Point | 266 °C(dec.) | |
MSDS | Chinese USA | Flash Point | 206.8±28.7 °C | |
Symbol |
GHS07, GHS09 |
Signal Word | Warning |
Use of ID 8ID-8 is a DYRK inhibitor, and sustains embryonic stem cell self-renewal in long-term culture.IC50 Value: Target: DYRKin vitro: the combination of Wnt and ID-8 enhanced hESC replating efficiency, and colonies expressed ALP and displayed undifferentiated morphology. members of the DYRK family are direct targets of ID-8 and that ID-8 enhances Wnt-mediated hESC survival and proliferation via inhibition of DYRKs [1]. ID-8 stimulated proliferation at a steady rate similar to LIF. ID-8 is required to maintain nanog, Sox2, and Rex-1 gene expression [2]. In vivo: |
Name | 1-(4-methoxyphenyl)-2-methyl-3-nitroindol-6-ol |
---|---|
Synonym | More Synonyms |
Description | ID-8 is a DYRK inhibitor, and sustains embryonic stem cell self-renewal in long-term culture.IC50 Value: Target: DYRKin vitro: the combination of Wnt and ID-8 enhanced hESC replating efficiency, and colonies expressed ALP and displayed undifferentiated morphology. members of the DYRK family are direct targets of ID-8 and that ID-8 enhances Wnt-mediated hESC survival and proliferation via inhibition of DYRKs [1]. ID-8 stimulated proliferation at a steady rate similar to LIF. ID-8 is required to maintain nanog, Sox2, and Rex-1 gene expression [2]. In vivo: |
---|---|
Related Catalog | |
References |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 418.3±45.0 °C at 760 mmHg |
Melting Point | 266 °C(dec.) |
Molecular Formula | C16H14N2O4 |
Molecular Weight | 298.293 |
Flash Point | 206.8±28.7 °C |
Exact Mass | 298.095367 |
PSA | 80.21000 |
LogP | 4.13 |
Vapour Pressure | 0.0±1.0 mmHg at 25°C |
Index of Refraction | 1.638 |
Symbol |
GHS07, GHS09 |
---|---|
Signal Word | Warning |
Hazard Statements | H302-H400 |
Precautionary Statements | P273 |
RIDADR | UN 3077 9 / PGIII |
~53% ID 8 CAS#:147591-46-6 |
Literature: Lyubchanskaya, V. M.; Alekseeva, L. M.; Granik, V. G. Chemistry of Heterocyclic Compounds (New York, NY, United States), 1992 , vol. 28, # 1 p. 34 - 39 Khimiya Geterotsiklicheskikh Soedinenii, 1992 , # 1 p. 40 - 45 |
~% ID 8 CAS#:147591-46-6 |
Literature: Lyubchanskaya, V. M.; Alekseeva, L. M.; Granik, V. G. Chemistry of Heterocyclic Compounds (New York, NY, United States), 1992 , vol. 28, # 1 p. 34 - 39 Khimiya Geterotsiklicheskikh Soedinenii, 1992 , # 1 p. 40 - 45 |
Precursor 2 | |
---|---|
DownStream 0 |
Validation of Perfusion Quantification with 3D Gradient Echo Dynamic Contrast-Enhanced Magnetic Resonance Imaging Using a Blood Pool Contrast Agent in Skeletal Swine Muscle.
PLoS ONE 10 , e0128060, (2015) The purpose of our study was to validate perfusion quantification in a low-perfused tissue by dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) with shared k-space sampling using a blood ... |
1-(4-Methoxy-phenyl)-2-methyl-3-nitro-1H-indol-6-ol |
1H-Indol-6-ol, 1-(4-methoxyphenyl)-2-methyl-3-nitro- |
ID-8 |
1-(4-Methoxyphenyl)-2-methyl-3-nitro-1H-indol-6-ol |
1-(4-methoxy-phenyl)-2-methyl-3-nitro-1H-indole-6-ol |
ID8 |